Toggle navigation
Home
Search
Services
Blog
Contact
About
Qualification of Drugs of Abuse and Related Substances in Biological Specimens
Moody, David E.
University of Utah, Salt Lake City, UT, United States
Search 154 grants from David Moody
Search grants from University of Utah
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
KLF4 and Transcriptional Control of Neovascularization
Novel Epigenetic Marks in Mitosis
Identification of populations of mammalian CPG neurons
Alpha Adrenoceptors in Vascular Wall Growth
Polysaccharides in Morphogenesis
Recently added grants:
Stem cell self-renewal programs in rhabdomyosarcoma
Randomized Trial of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer
Harnessing the CRL4 ubiquitin ligase for antagonizing colorectal carcinogenesis
A druggable dependency in low-MITF/high-AXL melanoma: preclinical efficacy and mechanism of action in a key treatment-resistant subclass.
Affective science and smoking cessation: Real time real world assessment
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research and Development Contracts (N01)
Project #
271200900005C-0-0-1
Application #
7908117
Study Section
Project Start
2009-02-27
Project End
2014-02-26
Budget Start
Budget End
Support Year
Fiscal Year
2009
Total Cost
$162,425
Indirect Cost
Institution
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Comments
Be the first to comment on David Moody's grant